Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Sitagliptin 100mg/5ml oral solution sugar free |
| BNF code | 0601023X0AAAFAF |
| Virtual Therapeutic Moiety | Sitagliptin |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✓ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Continuous |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Sitagliptin hydrochloride |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 423307000 |
| Strength value numerator | 20.000 |
| Strength value numerator unit | mg |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Ontology Drug Form & Route | |
| Form & Route | solution.oral |
| Dose Form | |
| Formulation | Oral solution |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Sitagliptin 100mg/5ml oral solution sugar free (Alliance Healthcare (Distribution) Ltd) | |
| Sitagliptin 100mg/5ml oral solution sugar free (Thame Laboratories Ltd) | |
| Virtual Medicinal Product Packs | |
| Sitagliptin 100mg/5ml oral solution sugar free 150 ml | |
dm+d data retrieved from TRUD: release NHSBSA_5.2.0_20240520000001, imported on 20th May 2024 at 05:03:18.